Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: The MRL-lpr mouse strain as a model

Autoimmunity Reviews

Volumn 13, Issue 9, 2014, Pages 963-973

  Jeltsch David, Hélène ^a   Muller, Sylviane ^a  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Animal model; Autoimmunity; Behavioral dysfunction; Cognition; Neurodegeneration; Phosphodiesterase

Indexed keywords

AUTOANTIBODY; CYTOKINE; IMMUNOGLOBULIN;

ANXIETY; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLIMBING; COGNITION; COGNITIVE DEFECT; ELEVATED PLUS MAZE TEST; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FEAR; FORCED SWIM TEST; INCLINED BEAM WALKING TEST; LEARNING AND MEMORY TEST; MORRIS WATER MAZE TEST; MOTOR PERFORMANCE; MOUSE; MOUSE MODEL; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NONHUMAN; OPEN FIELD TEST; REVIEW; SUCROSE PREFERENCE TEST; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; AUTOIMMUNITY; COMPLICATION; DISEASE MODEL; HUMAN; IMMUNOLOGY; LOCOMOTION;

ANIMALS; ANXIETY; AUTOIMMUNITY; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; LOCOMOTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

EID: 84922559193     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.08.015     Document Type: Review

References (181)

1. Bove R. Autoimmune diseases and reproductive aging. Clin Immunol 2013, 149:251-264.
2. Koga M., Kawasaki A., Ito I., Furuya T., Ohashi J., Kyogoku C., et al. Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population. J Hum Genet 2011, 56:503-507.
3. O'Neill S., Cervera R. Systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2010, 24:841-855.
4. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 2008, 358:929-939.
5. Rubtsov A.V., Rubtsova K., Kappler J.W., Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 2010, 9:494-498.
6. Tsokos G.C. Systemic lupus erythematosus. N Engl J Med 2011, 365:2110-2121.
7. Zandman-Goddard G., Solomon M., Rosman Z., Peeva E., Shoenfeld Y. Environment and lupus-related diseases. Lupus 2012, 21:241-250.
8. Bertsias G.K., Boumpas D.T. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol 2010, 6:358-367.
9. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599-608.
10. Bertsias G.K., Ioannidis J.P.A., Aringer M., Bollen E., Bombardieri S., Bruce I.N., et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010, 69:2074-2082.
11. Bertsias G.K., Pamfil C., Fanouriakis A., Boumpas D.T. Diagnostic criteria for systemic lupus erythematosus: has the time come?. Nat Rev Rheumatol 2013, 9:687-694.
12. Aranow C., Diamond B., Mackay M. Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 2010, 36:187-201.
13. Hanly J.G. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol 2014, 10:338-347.
14. Steup-Beekman G.M., Zirkzee E.J.M., Cohen D., Gahrmann B.M.A., Emmer B.J., Steens S.C.A., et al. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause. Ann Rheum Dis 2013, 72(Suppl. 2):76-79.
15. Petri M., Naqibuddin M., Carson K.A., Wallace D.J., Weisman M.H., Holliday S.L., et al. Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol 2010, 37:2032-2038.
16. Gulinello M., Putterman C. The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol 2011, 2011:1-15.
17. Kono D.H., Theofilopoulos A.N. Genetics of lupus in mice. Systemic lupus erythematosus 2011, 63-105. Elsevier, London. 5th ed. R.G. Lahita, G. Tsokos, J. Buyon, T. Koike (Eds.).
18. Theofilopoulos A.N., Dixon F.J. Murine models of systemic lupus erythematosus. Adv Immunol 1985, 37:269-390.
19. Ainiala H., Hietaharju A., Loukkola J., Peltola J., Korpela M., Metsänoja R., et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001, 45:419-423.
20. Kozora E., Ellison M.C., West S. Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Care Res 2004, 51:810-818.
21. Kozora E., Ellison M.C., West S. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Arthritis Rheum 2006, 55:628-635.
22. Carbotte R.M., Denburg S.D., Denburg J.A. Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatol 1995, 22:863-867.
23. Borowoy A.M., Pope J.E., Silverman E., Fortin P.R., Pineau C., Smith C.D., et al. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum 2012, 42:179-185.
24. Unterman A., Nolte J.E.S., Boaz M., Abady M., Shoenfeld Y., Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 2011, 41:1-11.
25. Brey R.L., Holliday S.L., Saklad A.R., Navarrete M.G., Hermosillo-Romo D., Stallworth C.L., et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002, 58:1214-1220.
26. Fragoso-Loyo H.E., Sánchez-Guerrero J. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus. J Rheumatol 2007, 34:76-80.
27. Morrison E., Carpentier S., Shaw E., Doucette S., Hanly J. Neuropsychiatric systemic lupus erythematosus: association with global disease activity. Lupus 2014, 370-377.
28. Zhou H.Q., Zhang F.C., Tian X.P., Leng X.M., Lu J.J., Zhao Y., et al. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients. Lupus 2008, 17:93-99.
29. Zirkzee E., Huizinga T., Bollen E., van Buchem M., Middelkoop H., van der Wee N., et al. Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus 2014, 23:31-38.
30. Zandman-Goddard G., Chapman J., Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 2007, 36:297-315.
31. Diamond B. Antibodies and the brain: lessons from lupus. J Immunol 2010, 185:2637-2640.
32. Diamond B., Kowal C., Huerta P.T., Aranow C., Mackay M., DeGiorgio L.A., et al. Immunity and acquired alterations in cognition and emotion: lessons from SLE. Adv Immunol 2006, 89:289-320.
33. Gono T., Kawaguchi Y., Yamanaka H. Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy. BMC Med 2013, 11:91.
34. Hirohata S., Kanai Y., Mitsuo A., Tokano Y., Hashimoto H., NPSLE Research Subcommittee Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. Clin Rheumatol 2009, 28:1319-1323.
35. Yokoyama T., Fujii T., Kondo-Ishikawa S., Yamakawa N., Nakano M., Yukawa N., et al. Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus. Lupus 2014, 23:635-642.
36. Yoshio T., Okamoto H., Hirohata S., Minota S. IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells. Arthritis Rheum 2013, 65:457-463.
37. Abbott N.J., Mendonça L.L.F., Dolman D.E.M. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003, 12:908-915.
38. Diamond B., Huerta P.T., Mina-Osorio P., Kowal C., Volpe B.T. Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol 2009, 9:449-456.
39. Stock A.D., Wen J., Putterman C. Neuropsychiatric lupus, the blood brain barrier, and the TWEAK/Fn14 pathway. Front Inflamm 2013, 4:484.
40. McLean B.N., Miller D., Thompson E.J. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system. J Neurol Neurosurg Psychiatry 1995, 58:548-554.
41. Nishimura K., Harigai M., Omori M., Sato E., Hara M. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology 2008, 33:395-403.
42. Sato T., Fujii T., Yokoyama T., Fujita Y., Imura Y., Yukawa N., et al. Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum 2010, 62:3730-3740.
43. Arinuma Y., Yanagida T., Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008, 58:1130-1135.
44. Fragoso-Loyo H., Cabiedes J., Orozco-Narváez A., Dávila-Maldonado L., Atisha-Fregoso Y., Diamond B., et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 2008, 3:e3347.
45. Greenwood D.L.V., Gitlits V.M., Alderuccio F., Sentry J.W., Toh B.-H. Autoantibodies in neuropsychiatric lupus. Autoimmunity 2002, 35:79-86.
46. Katsumata Y., Harigai M., Kawaguchi Y., Fukasawa C., Soejima M., Takagi K., et al. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J Rheumatol 2007, 34:2010-2017.
47. Yoshio T., Hirata D., Onda K., Nara H., Minota S. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol 2005, 32:34-39.
48. Ainiala H., Dastidar P., Loukkola J., Lehtimäki T., Korpela M., Peltola J., et al. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol 2005, 34:376-382.
49. Fitzgibbon B.M., Fairhall S.L., Kirk I.J., Kalev-Zylinska M., Pui K., Dalbeth N., et al. Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls. Rheumatology 2008, 47:50-53.
50. Peterson P.L., Axford J.S., Isenberg D. Imaging in CNS lupus. Best Pract Res Clin Rheumatol 2005, 19:727-739.
51. Sibbitt W.L., Brooks W.M., Kornfeld M., Hart B.L., Bankhurst A.D., Roldan C.A. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 2010, 40:32-52.
52. Toledano P., Sarbu N., Espinosa G., Bargalló N., Cervera R. Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features. Autoimmun Rev 2013, 12:1166-1170.
53. Zardi E.M., Taccone A., Marigliano B., Margiotta D.P.E., Afeltra A. Neuropsychiatric systemic lupus erythematosus: tools for the diagnosis. Autoimmun Rev 2014, 13:831-939.
54. Zimny A., Szmyrka-Kaczmarek M., Szewczyk P., Bladowska J., Pokryszko-Dragan A., Gruszka E., et al. In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging. Lupus 2014, 23:10-19.
55. Luyendijk J., Steens S.C.A., Ouwendijk W.J.N., Steup-Beekman G.M., Bollen E.L.E.M., van der Grond J., et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum 2011, 63:722-732.
56. Curiel R., Akin E.A., Beaulieu G., DePalma L., Hashefi M. PET/CT imaging in systemic lupus erythematosus. Ann N Y Acad Sci 2011, 1228:71-80.
57. Mak A., Ren T., Fu E.H., Cheak A.A., Ho R.C. A prospective functional MRI study for executive function in patients with systemic lupus erythematosus without neuropsychiatric symptoms. Semin Arthritis Rheum 2012, 41:849-858.
58. Sachdev P., Chen X., Wen W. White matter hyperintensities in mid-adult life. Curr Opin Psychiatry 2008, 21:268-274.
59. Kayser M.S., Dalmau J. The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin Neurosci 2011, 23:90-97.
60. Alexander J.J., Quigg R.J. Systemic lupus erythematosus and the brain: what mice are telling us. Neurochem Int 2007, 50:5-11.
61. Theofilopoulos A.N. Murine models of lupus. Systemic lupus erythematosus 1992, 121-194. Churchill Livingstone, New York. R.G. Lahita (Ed.).
62. Brey R.L., Sakic B., Szechtman H., Denburg J.A. Animal models for nervous system disease in systemic lupus erythematosus. Ann N Y Acad Sci 1997, 823:97-106.
63. Morel L. Genetics of SLE: evidence from mouse models. Nat Rev Rheumatol 2010, 6:348-357.
64. Perry D., Sang A., Yin Y., Zheng Y.-Y., Morel L. Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011, 2011.
65. Putterman C., Naparstek Y. Murine models of spontaneous systemic lupus erythematosus. Autoimmune disease models - a guidebook 1994, 245-255. Academic Press, San Diego. I.R. Cohen, A. Miller (Eds.).
66. Xu Y., Zeumer L., Reeves W.H., Morel L. Induced murine models of systemic lupus erythematosus. Systemic Lupus Erythematosus: Methods and Protocols 2014, vol. 1134:103-130. Springer Science+Business Media, New York.
67. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001, 7:1189-1193.
68. Huerta P.T., Kowal C., DeGiorgio L.A., Volpe B.T., Diamond B. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 2006, 103:678-683.
69. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., et al. Cognition and immunity: antibody impairs memory. Immunity 2004, 21:179-188.
70. Kowal C., DeGiorgio L.A., Lee J.Y., Edgar M.A., Huerta P.T., Volpe B.T., et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci 2006, 103:19854-19859.
71. Andrews B.S., Eisenberg R.A., Theofilopoulos A.N., Izui S., Wilson C.B., McConahey P.J., et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978, 148:1198-1215.
72. Murphy E.D., Roths J.B. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 1979, 22:1188-1194.
73. Watson M.L., Rao J.K., Gilkeson G.S., Ruiz P., Eicher E.M., Pisetsky D.S., et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 1992, 176:1645-1656.
74. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356:314-317.
75. Chu J.L., Drappa J., Parnassa A., Elkon K.B. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 1993, 178:723-730.
76. Williams S., Sakic B., Hoffman S.A. Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus. J Neuroimmunol 2010, 218:73-82.
77. Sakić B. The MRL model: an invaluable tool in studies of autoimmunity-brain interactions. Psychoneuroimmunology: methods and protocols 2012, 277-299. Springer Science+Business Media, New York. Q. Yan (Ed.).
78. Ballok D.A. Neuroimmunopathology in a murine model of neuropsychiatric lupus. Brain Res Rev 2007, 54:67-79.
79. Maric D., Millward J.M., Ballok D.A., Szechtman H., Denburg J.A., Barker J.L., et al. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice. Brain Res 2001, 920:183-193.
80. Sakić B., Szechtman H., Keffer M., Talangbayan H., Stead R., Denburg J.A. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav Immun 1992, 6:265-285.
81. Sakić B., Szechtman H., Denburg S., Carbotte R., Denburg J.A. Spatial learning during the course of autoimmune disease in MRL mice. Behav Brain Res 1993, 54:57-66.
82. Sakić B., Szechtman H., Talangbayan H., Denburg S.D., Carbotte R.M., Denburg J.A. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol Behav 1994, 56:609-617.
83. Sakic B., Lacosta S., Denburg J.A., Szechtman H. Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence. J Neuroimmunol 2002, 129:84-96.
84. Sakić B., Hanna S.E., Millward J.M. Behavioral heterogeneity in an animal model of neuropsychiatric lupus. Biol Psychiatry 2005, 57:679-687.
85. Szechtman H., Sakić B., Denburg J.A. Behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease. Lupus 1997, 6:223-229.
86. Vogelweid C.M., Wright D.C., Johnson J.C., Hewett J.E., Walker S.E. Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus. Arthritis Rheum 1994, 37:889-897.
87. Vogelweid C.M., Johnson G.C., Besch-Williford C.L., Basler J., Walker S.E. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J Neuroimmunol 1991, 35:89-99.
88. Sakić B., Kolb B., Whishaw I.Q., Gorny G., Szechtman H., Denburg J.A. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?. J Neuroimmunol 2000, 111:93-101.
89. Meszaros Z.S., Perl A., Faraone S.V. Psychiatric symptoms in systemic lupus erythematosus. J Clin Psychiatry 2012, 73:993-1001.
90. Gao H.-X., Campbell S.R., Cui M.-H., Zong P., Hwang J.-H., Gulinello M., et al. Depression is an early disease manifestation in lupus-prone MRL/lpr mice. J Neuroimmunol 2009, 207:45-56.
91. Malatynska E., Steinbusch H.W.M., Redkozubova O., Bolkunov A., Kubatiev A., Yeritsyan N.B., et al. Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: Implications for modeling elderly depression. Exp Gerontol 2012, 47:552-564.
92. Wen J., Xia Y., Stock A., Michaelson J.S., Burkly L.C., Gulinello M., et al. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway. J Autoimmun 2013, 43:44-54.
93. Ward M.M. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health 2004, 13:713-718.
94. Gao H.-X., Sanders E., Tieng A.T., Putterman C. Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice. J Neuroimmunol 2010, 229:112-122.
95. Sidor M.M., Sakic B., Malinowski P.M., Ballok D.A., Oleschuk C.J., Macri J. Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice. J Neuroimmunol 2005, 165:104-113.
96. Ballok D.A., Woulfe J., Sur M., Cyr M., Sakic B. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus 2004, 14:649-661.
97. Sakić B., Szechtman H., Denburg J.A. Neurobehavioral alterations in autoimmune mice. Neurosci Biobehav Rev 1997, 21:327-340.
98. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
99. Nielsen D.M., Crnic L.S. Elevated plus maze behavior, auditory startle response, and shock sensitivity in predisease and in early stage autoimmune disease MRL/lpr mice. Brain Behav Immun 2002, 16:46-61.
100. Simon P., Dupuis R., Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 1994, 61:59-64.
101. Grota L.J., Ader R., Cohen N. Taste aversion learning in autoimmune Mrl-lpr/lpr and Mrl +/+mice. Brain Behav Immun 1987, 1:238-250.
102. Ballok D.A., Szechtman H., Sakic B. Taste responsiveness and diet preference in autoimmune MRL mice. Behav Brain Res 2003, 140:119-130.
103. Sakić B., Szechtman H., Braciak T., Richards C., Gauldie J., Denburg J.A. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res Bull 1997, 44:155-165.
104. Anderson K.K., Ballok D.A., Prasad N., Szechtman H., Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behav Brain Res 2006, 166:32-38.
105. Ballok D.A., Earls A.M., Krasnik C., Hoffman S.A., Sakic B. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. J Neuroimmunol 2004, 152:83-97.
106. Sakić B., Denburg J.A., Denburg S.D., Szechtman H. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res Bull 1996, 41:305-311.
107. Katzav A., Solodeev I., Brodsky O., Chapman J., Pick C.G., Blank M., et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007, 56:938-948.
108. Porsolt R.D., Bertin A., Jalfre M. "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 1978, 51:291-294.
109. Porsolt R.D. Animal model of depression. Biomedicine 1979, 30:139-140.
110. Sakić B., Laflamme N., Crnic L.S., Szechtman H., Denburg J.A., Rivest S. Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction. J Neuroimmunol 1999, 96:80-91.
111. Sakić B., Szechtman H., Denburg S.D., Denburg J.A. Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice. Physiol Behav 1995, 58:797-802.
112. Hess D.C., Taormina M., Thompson J., Sethi K.D., Diamond B., Rao R., et al. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J Rheumatol 1993, 20:610-617.
113. Feeney D.M., Gonzalez A., Law W.A. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982, 217:855-857.
114. Costall B., Eniojukan J.F., Naylor R.J. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse. Psychopharmacology (Berl) 1985, 86:452-457.
115. Abbott N.J., Patabendige A.A.K., Dolman D.E.M., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37:13-25.
116. Jacob A., Hack B., Chiang E., Garcia J.G.N., Quigg R.J., Alexander J.J. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J 2010, 24:1682-1688.
117. Ma X., Foster J., Sakic B. Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice. J Neuroimmunol 2006, 179:26-36.
118. Lapteva L., Nowak M., Yarboro C.H., Takada K., Roebuck-Spencer T., Weickert T., et al. Anti-N-methyl-d-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006, 54:2505-2514.
119. Tin S.K., Xu Q., Thumboo J., Lee L.Y., Tse C., Fong K.Y. Novel brain reactive autoantibodies: prevalence in systemic lupus erythematosus and association with psychoses and seizures. J Neuroimmunol 2005, 169:153-160.
120. Hirohata S., Hirose S., Miyamoto T. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity. Arch Intern Med 1985, 145:1843-1846.
121. Winfield J.B., Shaw M., Silverman L.M., Eisenberg R.A., Wilson H.A., Koffler D. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 1983, 74:837-844.
122. Stanojcic M., Loheswaran G., Xu L., Hoffman S.A., Sakic B. Intrathecal antibodies and brain damage in autoimmune MRL mice. Brain Behav Immun 2010, 24:289-297.
123. Sakić B., Kirkham D.L., Ballok D.A., Mwanjewe J., Fearon I.M., Macri J., et al. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J Neuroimmunol 2005, 169:68-85.
124. Yoshio T., Onda K., Nara H., Minota S. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2006, 54:675-678.
125. Dean G.S., Tyrrell-Price J., Crawley E., Isenberg D.A. Cytokines and systemic lupus erythematosus. Ann Rheum Dis 2000, 59:243-251.
126. Arisi G.M. Nervous and immune systems signals and connections: cytokines in hippocampus physiology and pathology. Epilepsy Behav 2014, http://dx.doi.org/101016/J.yebeh.2014.01.17 [in press].
127. Dinan T.G. Inflammatory markers in depression. Curr Opin Psychiatry 2009, 22:32-36.
128. Fragoso-Loyo H., Richaud-Patin Y., Orozco-Narváez A., Dávila-Maldonado L., Atisha-Fregoso Y., Llorente L., et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007, 56:1242-1250.
129. Fragoso-Loyo H., Cabiedes J., Richaud-Patin Y., Orozco-Narváez A., Diamond B., Llorente L., et al. Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors. Rheumatology 2009, 48:1615-1616.
130. Svenungsson E., Andersson M., Brundin L., van Vollenhoven R., Khademi M., Tarkowski A., et al. Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis 2001, 60:372-379.
131. Szelényi J. Cytokines and the central nervous system. Brain Res Bull 2001, 54:329-338.
132. Yang I., Han S.J., Kaur G., Crane C., Parsa A.T. The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci 2010, 17:6-10.
133. Johansson S., Price J., Modo M. Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells. Stem Cells 2008, 26:2444-2454.
134. Patterson P.H., Nawa H. Neuronal differentiation factors/cytokines and synaptic plasticity. Cell 1993, 72:123-137. [Suppl.].
135. Li P., Lin W., Zheng X. IL-33 neutralization suppresses lupus disease in lupus-prone mice. Inflammation 2014, 1-9.
136. Tang B., Matsuda T., Akira S., Nagata N., Ikehara S., Hirano T., et al. Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 1991, 3:273-278.
137. Tsai C.Y., Wu T.H., Huang S.F., Sun K.H., Hsieh S.C., Han S.H., et al. Abnormal splenic and thymic IL-4 and TNF-alpha expression in MRL-lpr/lpr mice. Scand J Immunol 1995, 41:157-163.
138. Anisman H., Hayley S. Inflammatory factors contribute to depression and its comorbid conditions. Sci Signal 2012, 5:pe45.
139. Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am 2009, 29:247-264.
140. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
141. Oitzl M.S., van Oers H., Schöbitz B., de Kloet E.R. Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res 1993, 613:160-163.
142. Santoro T.J., Tomita M., Larson S.J. The potential impact of sickness-motivated behavior on the expression of neuropsychiatric disturbances in systemic lupus erythematosus. Med Hypotheses 2007, 69:502-507.
143. Tomita M., Holman B.J., Santoro T.J. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett 2001, 302:129-132.
144. Tomita M., Holman B.J., Williams L.S., Pang K.C., Santoro T.J. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J Neurosci Res 2001, 64:26-33.
145. Tomita M., Khan R.L., Blehm B.H., Santoro T.J. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med Hypotheses 2004, 62:325-335.
146. Alexander J.J., Jacob A., Bao L., Macdonald R.L., Quigg R.J. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J Immunol 2005, 175:8312-8319.
147. Alexander J.J., Zwingmann C., Quigg R. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy. Neurochem Int 2005, 47:143-151.
148. Zameer A., Hoffman S.A. B and T cells in the brains of autoimmune mice. J Neuroimmunol 2004, 146:133-139.
149. Zameer A., Hoffman S.A. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J Neuroimmunol 2003, 142:67-74.
150. Sherman G.F., Galaburda A.M., Behan P.O., Rosen G.D. Neuroanatomical anomalies in autoimmune mice. Acta Neuropathol 1987, 74:239-242.
151. Sherman G.F., Morrison L., Rosen G.D., Behan P.O., Galaburda A.M. Brain abnormalities in immune defective mice. Brain Res 1990, 532:25-33.
152. Sakić B., Szechtman H., Denburg J.A., Gorny G., Kolb B., Whishaw I.Q. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J Neuroimmunol 1998, 87:162-170.
153. Denenberg V.H., Sherman G.F., Rosen G.D., Morrison L., Behan P.O., Galaburda A.M. A behavior profile of the MRL/Mp lpr/lpr mouse and its association with hydrocephalus. Brain Behav Immun 1992, 6:40-49.
154. Sled J.G., Spring S., van Eede M., Lerch J.P., Ullal S., Sakic B. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus. Arthritis Rheum 2009, 60:1764-1774.
155. Ballok D.A., Millward J.M., Sakic B. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res 2003, 964:200-210.
156. Sakić B., Gurunlian L., Denburg S.D. Reduced aggressiveness and low testosterone levels in autoimmune MRL-lpr males. Physiol Behav 1998, 63:305-309.
157. Kozora E., Brown M.S., Filley C.M., Zhang L., Miller D.E., West S.G., et al. Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus. Lupus 2011, 20:598-606.
158. Schnider A., Bassetti C., Schnider A., Gutbrod K., Ozdoba C. Very severe amnesia with acute onset after isolated hippocampal damage due to systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1995, 59:644-646.
159. Shapira-Lichter I., Vakil E., Litinsky I., Oren N., Glikmann-Johnston Y., Caspi D., et al. Learning and memory-related brain activity dynamics are altered in systemic lupus erythematosus: a functional magnetic resonance imaging study. Lupus 2013, 22:562-573.
160. Yamashita T., Ninomiya M., Hernández Acosta P., García-Verdugo J.M., Sunabori T., Sakaguchi M., et al. Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neurosci 2006, 26:6627-6636.
161. Sakić B., Maric I., Koeberle P.D., Millward J.M., Szechtman H., Maric D., et al. Increased TUNEL staining in brains of autoimmune Fas-deficient mice. J Neuroimmunol 2000, 104:147-154.
162. Stanojcic M., Burstyn-Cohen T., Nashi N., Lemke G., Sakic B. Disturbed distribution of proliferative brain cells during lupus-like disease. Brain Behav Immun 2009, 23:1003-1013.
163. Zola-Morgan S., Squire L.R. The neuropsychology of memory. Parallel findings in humans and nonhuman primates. Ann N Y Acad Sci 1990, 608:434-456.
164. Lechner O., Dietrich H., Oliveira dos Santos A., Wiegers G.J., Schwarz S., Harbutz M., et al. Altered circadian rhythms of the stress hormone and melatonin response in lupus-prone MRL/MP-fas(Ipr) mice. J Autoimmun 2000, 14:325-333.
165. Chun S., McEvilly R., Foster J.A., Sakic B. Proclivity to self-injurious behavior in MRL-lpr mice: implications for autoimmunity-induced damage in the dopaminergic system. Mol Psychiatry 2008, 13:1043-1053.
166. Schäfer A., Scheurlen M., Seufert J., Keicher C., Weißbrich B., Rieger P., et al. Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression. J Hepatol 2010, 52:10-15.
167. Asanuma M., Miyazaki I., Ogawa N. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotox Res 2003, 5:165-176.
168. Shanks N., Moore P.M., Perks P., Lightman S.L. Alterations in hypothalamic-pituitary-adrenal function correlated with the onset of murine SLE in MRL +/+and lpr/lpr mice. Brain Behav Immun 1999, 13:348-360.
169. Hayley S., Merali Z., Anisman H. Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress 2003, 6:19-32.
170. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
171. Raison C.L., Miller A.H. Is depression an inflammatory disorder?. Curr Psychiatry Rep 2011, 13:467-475.
172. Del Rey A., Besedovsky H.O. The cytokine-HPA axis circuit contributes to prevent or moderate autoimmune processes. Z Rheumatol 2000, 59(Suppl. 2):31-35.
173. Spangelo B.L., Judd A.M., Call G.B., Zumwalt J., Gorospe W.C. Role of the cytokines in the hypothalamic-pituitary-adrenal and gonadal axes. Neuroimmunomodulation 1995, 2:299-312.
174. Loheswaran G., Kapadia M., Gladman M., Pulapaka S., Xu L., Stanojcic M., et al. Altered neuroendocrine status at the onset of CNS lupus-like disease. Brain Behav Immun 2013, 32:86-93.
175. Yougbaré I., Keravis T., Abusnina A., Decossas M., Schall N., Muller S., et al. Cyclic GMP catabolism up-regulation in MRL/lpr lupus-prone mice is associated with organ remodeling. Biochim Biophys Acta 2014, 1842:916-926.
176. Menniti F.S., Faraci W.S., Schmidt C.J. Phosphodiesterases in the CNS: targets for drug development. Nat Rev Drug Discov 2006, 5:660-670.
177. Owens T., Wekerle H., Antel J. Genetic models for CNS inflammation. Nat Med 2001, 7:161-166.
178. Jeltsh-David H., Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol 2014, [in press].
179. Hanly J.G. Reply. Arthritis Rheumatol 2014, 66:1059-1060.
180. Hanly J.G., Urowitz M.B., O'Keeffe A.G., Gordon C., Bae S.-C., Sanchez-Guerrero J., et al. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum 2013, 65:2887-2897.
181. Mitsikostas D.D., Katsiari C., Sfikakis P.P. "Lupus headache" may not exist: comment on the article of Hanly et al. Arthritis Rheumatol 2014, 66:1058. 10.10002/art38333.